ROLE OF ALPHA-KLOTHO PROTEIN IN FIBROGENESIS AT DIFFERENT STAGES OF DIABETIC NEPHROPATHY
-
Published:2022-10-01
Issue:
Volume:
Page:12-14
-
ISSN:
-
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
-
language:en
-
Short-container-title:ijsr
Author:
Kavuparambil Liji1, Kumar Pammi Ashok2
Affiliation:
1. Assistant Professor, MES Medical College, Kerala, India. 2. Professor & HOD, Rajah Muttiah Medical College, Annamalai University, Tamil Nadu, India.
Abstract
Introduction: Alpha Klotho protein monitoring in diabetic nephropathy patients is important because the deciency appears to be a risk factor for
the development and progression of diabetic nephropathy and thus has prognostic value. There is conicting evidence regarding the relationship
between Alpha Klotho protein and brogenesis in diabetic nephropathy. A 2-year cross-s Methods: ectional study of 120 diabetic patients, with and
without nephropathy enrolled at MES Medical College. Alpha Klotho protein and the brogenesis regulator, TGF-β1 were measured using ELISA.
Results: Conclusion: In diabetic nephropathy patients, Alpha-Klotho protein had a signicant negative correlation with TGF-β1 and eGFR.
Alpha-Klotho protein levels have been found to be lower in diabetic nephropathy patients and signicantly related to the severity of the disease.
Alpha-KL protein also correlated signicantly with the marker of brogenesis, TGF- beta 1. So it has a value as a prognostic marker and role in
preventing brogenesis in diabetic patients.
Publisher
World Wide Journals
Subject
Virology,Infectious Diseases,Microbiology (medical),Microbiology,Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine,Immunology,Immunology and Allergy,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Dermatology,Endocrinology, Diabetes and Metabolism,Gastroenterology,Hepatology,Hematology,Biomedical Engineering,General Medicine,Surgery,Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine
Reference22 articles.
1. Dabla P. K. (2010). Renal function in diabetic nephropathy. World journal of diabetes, 1(2), 48–56 2. Doi, S., Zou, Y., Togao, O., Pastor, J. V., John, G. B., Wang, L., Shiizaki, K., Gotschall, R., Schiavi, S., Yorioka, N., Takahashi, M., Boothman, D. A., & Kuro-O, M. (2011). Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. The Journal of biological chemistry, 286(10), 8655–8665. https://doi.org/10.1074/jbc.M110.174037. 3. El Chaar M., Chen J., Seshan S. V., Jha S., Richardson I., Ledbetter S. R., Vaughan E. D., Jr., Poppas D. P., Felsen D. (2007) Am. J. Physiol. Renal Physiol. 292, F1291–F1301. 4. Gewin, L. S. (2020). TGF-β and diabetic nephropathy: lessons learned over the past 20 years. The American journal of the medical sciences, 359(2), 70-72. 5. Haruna Y., Kashihara N., Satoh M., Tomita N., Namikoshi T., Sasaki T., Fujimori T., Xie P., Kanwar Y. S. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 2331–2336
|
|